Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Kristen M Oelschlager is Chief Operating Officer at Castle Biosciences. OQRO lists 6 transactions filed with the SEC under this name, the latest on Oct 6, 2026, each linked to the official Form 4.
Chief Operating Officer
Disclosures on record
6
Companies involved
1
Kristen M Oelschlager has no open-market purchase on record since 2021. Sales in each of the last 3 years.
Kristen M Oelschlager reported 0 open-market purchases and 12 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $149K2×2 trades |
| 2025 | — | $670K2×2 trades |
| 2024 | — | $591K6×6 trades |
| 2021 | — | $710K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Castle BiosciencesCSTL
6 disclosures · Aug 2025 – Oct 2026 · 4 sold
Oct 1, 2026Sold~$100Kdisclosed Oct 6
DetailsOfficial recordOct 1, 2026Sold~$49Kdisclosed Oct 6
DetailsOfficial recordOct 1, 20264,153disclosed Oct 6
DetailsOfficial recordOct 1, 20264,153disclosed Oct 6
DetailsOfficial recordAug 27, 2025Sold~$391Kdisclosed Aug 29
DetailsOfficial recordAug 27, 2025Sold~$279Kdisclosed Aug 29
DetailsOfficial recordAs of the latest filing on , Kristen M Oelschlager reported holding 13,356 shares of Castle Biosciences (CSTL), worth about $451K at the last close of $34 (Nov 13, 2026). In the last 12 months, Kristen M Oelschlager sold $149K in 2 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Castle Biosciences CSTL | 13,356 | 13K direct | $34 | $451K | Oct 1, 2026 |
Is this Kristen M Oelschlager’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Kristen M Oelschlager reported 0 open-market purchases and 12 sales here, 2021 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Oct 1, 2026, Kristen M Oelschlager reported holding 13,356 shares of Castle Biosciences (CSTL). At the last close of $34 on Nov 13, 2026, that is about $451K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Kristen M Oelschlager reported 2 open-market sales worth $149K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Kristen M Oelschlager has no open-market purchase on record since 2021. Sales in each of the last 3 years.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2026.
Castle Biosciences (CSTL), from 2021 to 2026: 0 purchases and 12 sales.